Difference between revisions of "PET Amyloid Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
(9 intermediate revisions by 2 users not shown)
Line 20: Line 20:
 
==PET Amyloid Meetings/Call Summaries==
 
==PET Amyloid Meetings/Call Summaries==
  
*[[Media:2020_05-08_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|May 8, 2020]]
+
*[[Media:2021_06-11_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|June 11, 2021]]
*[[Media:2020_03-13_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL-AMS-2.pdf|March 13, 2020]]
+
*[[Media:2021_05-14_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|May 14, 2021]]
*[[Media:2020_02-14_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|February 14, 2020]]
+
*[[Media:2021_04-09_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL-AMS.pdf|April 9, 2021]]
*[[Media:2019_09-13_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|September 13, 2019]]
+
*[[Media:2021_03-12_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|March 12, 2021]]
*[[Media:2019_07-12_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|July 12, 2019]]
+
*[[Media:2021_02-12_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|February 12, 2021]]
*[[Media:2019_03-08_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|March 8, 2019]]
+
 
*[[Media:2019_02-08_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL-AMS.pdf|February 8, 2019]]
+
 
*[[Media:2019_01-11_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL-DM.pdf|January 11, 2019]]
 
  
 
'''''[[PET Amyloid BC Call Summaries Archive]]'''''
 
'''''[[PET Amyloid BC Call Summaries Archive]]'''''

Revision as of 16:26, 24 May 2021

Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
RSNA Staff Support: Julie Lisiecki


Project Snapshot

There is a draft Profile, and current outline of the Claim is:

  • SUVr will be the measurand
  • The claim will have two components
1) Cross-sectional: single subject scan
2) Longitudinal: following subject over time

Due to the complexity of having multiple PET Amyloid tracers, a subgroup, the Test-retest Group, has been formed including academics and industry representatives from all of the major PET Amyloid tracer vendors. This group will evaluate the published data on amyloid imaging precision, to determine what level of precision can be claimed in the Profile. The committee’s goal is to have a final draft Profile by December, 2015.

Collaborations: RSNA QIBA is now an affiliate of GAAIN (Global Alzheimer’s Association International Network)

PET Amyloid Meetings/Call Summaries


PET Amyloid BC Call Summaries Archive

PET Amyloid Profile Development

Profile Supporting Material

Working Documents

Presentations and Reports

QIBA Funded Projects

Round 4

Round 5